​

XORTX Therapeutics Ownership | Who Owns XORTX Therapeutics?

OverviewFinancialsChart

XORTX Therapeutics Ownership Summary

XORTX Therapeutics is owned by 0.65% institutional investors, and 99.35% retail investors.

XRTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockXORTX Therapeutics0.65%-99.35%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20234-12,938-68.44%-15.45%1---
Jun 30, 20234-33.33%40,994-42.62%214.96%1-75.00%--
Mar 31, 20236-14.29%71,446-95.35%30.03%4-20.00%--
Dec 31, 20227133.33%1,535,8566008.73%1033415.87%5150.00%--100.00%
Sep 30, 20223-25,142-25.21%132.13%2-1-

XRTX Ownership FAQ

Who Owns XORTX Therapeutics?

XORTX Therapeutics shareholders are primarily institutional investors at 0.65%, followed by 0% insiders and 0% retail investors. The average institutional ownership in XORTX Therapeutics's industry, Biotech Stocks , is 47.04%, which XORTX Therapeutics falls below.

Does Blackrock own XORTX Therapeutics?

BlackRock is not among the top 10 institutional shareholders of XORTX Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools